GLENMARK.NS Profit & Loss

Glenmark Pharmaceuticals Ltd.

Profit & Loss · 4 years on file (FY2022-23 to FY2025-26) · fetched 2026-08-23 22:31

Line item	FY2022-23	FY2023-24	FY2024-25	FY2025-26	Source (XBRL element)
Revenue from Operations	₹129.90 Bn	₹118.13 Bn	₹133.22 Bn	₹169.83 Bn	RevenueFromOperations
Gross Revenue (incl. inter-segment)	N/A	N/A	N/A	N/A	SegmentRevenueFromOperations
Other Income	₹3.17 Bn	₹8.40 Bn	₹1.14 Bn	₹4.61 Bn	OtherIncome
Total Income	₹133.07 Bn	₹126.53 Bn	₹134.35 Bn	₹174.43 Bn	Income
Cost of Materials Consumed	₹35.94 Bn	₹31.58 Bn	₹30.01 Bn	₹29.61 Bn	CostOfMaterialsConsumed
Purchases of Stock-in-Trade	₹12.68 Bn	₹14.51 Bn	₹15.66 Bn	₹23.97 Bn	PurchasesOfStockInTrade
Changes in Inventories	₹-3.25 Bn	₹-1.96 Bn	₹-2.14 Bn	₹-6.11 Bn	ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense	₹27.81 Bn	₹28.68 Bn	₹30.22 Bn	₹35.78 Bn	EmployeeBenefitExpense
Finance Costs	₹3.50 Bn	₹5.16 Bn	₹2.07 Bn	₹2.09 Bn	FinanceCosts
Depreciation and Amortisation	₹6.11 Bn	₹5.82 Bn	₹4.86 Bn	₹5.73 Bn	DepreciationDepletionAndAmortisationExpense
Other Expenses	₹33.94 Bn	₹33.36 Bn	₹35.95 Bn	₹40.85 Bn	OtherExpenses
Total Expenses	₹116.73 Bn	₹117.16 Bn	₹116.63 Bn	₹131.92 Bn	Expenses
Profit Before Exceptional Items and Tax	₹16.34 Bn	₹9.37 Bn	₹17.72 Bn	₹42.51 Bn	ProfitBeforeExceptionalItemsAndTax
Exceptional Items	₹-7.66 Bn	₹-9.01 Bn	₹-3.73 Bn	₹-22.66 Bn	ExceptionalItemsBeforeTax
Profit Before Tax	₹8.68 Bn	₹0.36 Bn	₹13.99 Bn	₹19.85 Bn	ProfitBeforeTax
Tax Expense	₹4.91 Bn	₹18.67 Bn	₹3.52 Bn	₹6.23 Bn	TaxExpense
Net Profit (incl. minority interest)	₹3.77 Bn	₹-14.34 Bn	₹10.47 Bn	₹13.62 Bn	ProfitLossForPeriod
Net Profit (to shareholders)	₹0.00 Bn	₹-15.02 Bn	₹10.47 Bn	₹0.00 Bn	ProfitOrLossAttributableToOwnersOfParent
Basic EPS	₹10.53	₹-53.22	₹37.11	₹48.26	BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS	₹10.53	₹-53.22	₹37.10	₹48.24	DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from GLENMARK.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).